Varex Imaging $VREX Stock Purchased by Royce & Associates LP

Royce & Associates LP boosted its position in Varex Imaging (NASDAQ:VREX – Free Report) by 12.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 980,958 shares of the company’s stock after purchasing an additional 108,165 shares during the period. Royce & Associates LP’s holdings in Varex Imaging were worth $18,099,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in VREX. Russell Investments Group Ltd. increased its position in shares of Varex Imaging by 32.5% during the 3rd quarter. Russell Investments Group Ltd. now owns 114,846 shares of the company’s stock valued at $2,119,000 after purchasing an additional 28,184 shares during the period. New York Life Investment Management LLC bought a new stake in shares of Varex Imaging in the 3rd quarter worth $1,384,000. Parallel Advisors LLC raised its stake in shares of Varex Imaging by 307.2% in the 3rd quarter. Parallel Advisors LLC now owns 1,865 shares of the company’s stock worth $34,000 after buying an additional 1,407 shares in the last quarter. Inspire Investing LLC raised its stake in shares of Varex Imaging by 154.7% in the 3rd quarter. Inspire Investing LLC now owns 168,685 shares of the company’s stock worth $3,112,000 after buying an additional 102,455 shares in the last quarter. Finally, Fortitude Family Office LLC raised its stake in shares of Varex Imaging by 1,643.6% in the 3rd quarter. Fortitude Family Office LLC now owns 2,441 shares of the company’s stock worth $45,000 after buying an additional 2,301 shares in the last quarter.

Varex Imaging Price Performance

VREX stock opened at $18.10 on Monday. Varex Imaging has a 12 month low of $9.09 and a 12 month high of $18.63. The firm has a market cap of $768.53 million, a PE ratio of 34.81 and a beta of 1.02. The firm has a 50 day simple moving average of $18.45 and a 200 day simple moving average of $13.85. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.38 and a quick ratio of 1.53.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on VREX. B. Riley Financial lowered Varex Imaging from a “buy” rating to a “hold” rating in a report on Monday, August 10th. Weiss Ratings raised Varex Imaging from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. CJS Securities lowered Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Sidoti cut shares of Varex Imaging from a “buy” rating to a “neutral” rating and set a $19.00 price target on the stock. in a research report on Monday, August 10th. Finally, Oppenheimer downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Seven equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $16.88.

Read Our Latest Report on Varex Imaging

Insider Activity at Varex Imaging

In other Varex Imaging news, CFO Shubham Maheshwari sold 130,000 shares of the company’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $18.46, for a total value of $2,399,800.00. Following the transaction, the chief financial officer owned 139,972 shares of the company’s stock, valued at approximately $2,583,883.12. This represents a 48.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jay K. Kunkel sold 8,121 shares of the stock in a transaction on Monday, September 14th. The shares were sold at an average price of $18.48, for a total value of $150,076.08. Following the sale, the director owned 15,329 shares of the company’s stock, valued at $283,279.92. This trade represents a 34.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 4.60% of the company’s stock.

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs and manufactures components used in X-ray imaging systems. Its products include X-ray tubes, digital detectors, image-processing solutions and related software and services for medical and industrial applications. In healthcare, Varex’s components are used in systems for applications such as radiography, computed tomography, mammography and oncology. Its industrial products support inspection and analysis in areas including security screening and nondestructive testing.

Recommended Stories

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX – Free Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.